Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre C Kalil

Showing results (31-40 of 277) with videos related to

Pageof 28
Sort By:
Critical Care Medicine|November 21, 2025
What Impacts Sepsis Outcomes in Low- and Middle-Income Countries: Antibiotic Timing, Presence of Shock, or Supportive Care?Lama Nazer, Andre C Kalil
Critical Care Medicine|February 19, 2014
The "last breath" of the ventilator-associated pneumonia surveillance definition*Michael Klompas, Andre C Kalil
Critical Care Medicine|April 18, 2020
Any Role for Biomarker-Guide Algorithms in Antibiotic Stewardship Programs?Pedro Povoa, Andre C Kalil
Critical Care Medicine|March 19, 2025
Early Antibiotic Initiation and Survival in Hospital-Acquired PneumoniaSubhadra Mandadi, Andre C Kalil
Critical Care Medicine|September 17, 2014
Bayesian methodology for the design and interpretation of clinical trials in critical care medicine: a primer for cliniciansAndre C Kalil, Junfeng Sun
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 28, 2022
Omicron variant: assessing the duration of viral shedding and its implicationsMuge Cevik, Andre C Kalil
Intensive Care Medicine|January 19, 2011
Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversiesAndre C Kalil, Junfeng Sun
Current Opinion in Critical Care|August 5, 2017
Pneumonia with bacterial and viral coinfectionKelly Cawcutt, Andre C Kalil
Intensive Care Medicine|May 28, 2008
How many patients with severe sepsis are needed to confirm the efficacy of drotrecogin alfa activated? A Bayesian designAndre C Kalil, Junfeng Sun
Critical Care Medicine|June 19, 2018
Rethinking Ventilator BundlesMichael Klompas, Andre C Kalil
Pageof 28

Showing results (31-40 of 277) with videos related to

Sort By:
Pageof 28
Critical Care Medicine|November 21, 2025
What Impacts Sepsis Outcomes in Low- and Middle-Income Countries: Antibiotic Timing, Presence of Shock, or Supportive Care?Lama Nazer, Andre C Kalil
Critical Care Medicine|February 19, 2014
The "last breath" of the ventilator-associated pneumonia surveillance definition*Michael Klompas, Andre C Kalil
Critical Care Medicine|April 18, 2020
Any Role for Biomarker-Guide Algorithms in Antibiotic Stewardship Programs?Pedro Povoa, Andre C Kalil
Critical Care Medicine|March 19, 2025
Early Antibiotic Initiation and Survival in Hospital-Acquired PneumoniaSubhadra Mandadi, Andre C Kalil
Critical Care Medicine|September 17, 2014
Bayesian methodology for the design and interpretation of clinical trials in critical care medicine: a primer for cliniciansAndre C Kalil, Junfeng Sun
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 28, 2022
Omicron variant: assessing the duration of viral shedding and its implicationsMuge Cevik, Andre C Kalil
Intensive Care Medicine|January 19, 2011
Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversiesAndre C Kalil, Junfeng Sun
Current Opinion in Critical Care|August 5, 2017
Pneumonia with bacterial and viral coinfectionKelly Cawcutt, Andre C Kalil
Intensive Care Medicine|May 28, 2008
How many patients with severe sepsis are needed to confirm the efficacy of drotrecogin alfa activated? A Bayesian designAndre C Kalil, Junfeng Sun
Critical Care Medicine|June 19, 2018
Rethinking Ventilator BundlesMichael Klompas, Andre C Kalil
Pageof 28